Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Genitourinary 7Gastrointestinal 7Head & Neck 3Thoracic 1Sarcoma 1Other solid neoplasm 1Gynecologic 1Dermatologic 1

Conditions

Head and Neck Neoplasms 2Thyroid Neoplasms 1Recurrence 1Breast Neoplasms 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × perflutren × Head & Neck × Clear all
NCT07501650 2026-03-30

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Thomas Jefferson University

Phase 1 Recruiting
6 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence

NCT04136912 2025-10-06

3-D Super Resolution Ultrasound Microvascular Imaging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
27 enrolled 12 charts
BreastHead & Neck

Breast Neoplasms, Thyroid Neoplasms

NCT04431648 2023-12-13

USmBRT-H

Sunnybrook Health Sciences Centre

Phase 1 Unknown
20 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡